Clinical Trials Logo

GERD clinical trials

View clinical trials related to GERD.

Filter by:

NCT ID: NCT02620501 Recruiting - Dysphagia Clinical Trials

Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time

Start date: July 2015
Phase: N/A
Study type: Interventional

Patients will be randomized to a placebo or study group who will receive topical lidocaine prior to EGD. Amount of medication used, recovery time, patient/endoscopist satisfaction will then be assessed.

NCT ID: NCT02616302 Recruiting - Clinical trials for Gastroesophageal Reflux Disease (GERD)

A Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children

Start date: February 20, 2023
Phase: Phase 2
Study type: Interventional

The main aims of the study are to see the - side effects of Dexlansoprazole treatment - effectiveness of Dexlansoprazole treatment in children having symptomatic nonerosive gastroesophageal reflux disease (GERD). Participants will take Dexlansoprazole by mouth once daily for 12 weeks

NCT ID: NCT02587910 Recruiting - GERD Clinical Trials

Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease

GERDMeDS
Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Melanole, a Nigella sativa (Black Seed) extract , is studied for the treatment of GERD. Participants, who meet the inclusion criteria, will be divided into two arms. Arm 1: Subjects who meet criteria for GERD will undergo 24 hour pH monitoring. Arm 2: Subjects who meet criteria for GERD and who undergo only symptomatic monitoring of GERD on treatment. All participants will be evaluated before and after the administration of the study product.

NCT ID: NCT02479438 Recruiting - GERD Clinical Trials

Gastroesophageal Reflux Disease Prospective Registry

GERD
Start date: January 2014
Phase:
Study type: Observational [Patient Registry]

The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.

NCT ID: NCT02366169 Recruiting - Clinical trials for Gastroesophageal Reflux Disease (GERD)

Medigus Ultrasonic Surgical Endostapler (MUSE) Registry

Start date: March 2015
Phase: N/A
Study type: Observational [Patient Registry]

This registry is intended as an observational, post-marketing surveillance tool. The registry allows collection of baseline demographics and user experience of the commercially available MUSE system. Data collection aims to aggregate a minimum of 3 years follow-up on a large number of subjects during use outside the constraints of a prescribed clinical study.

NCT ID: NCT02210975 Recruiting - GERD Clinical Trials

An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients After Sleeve Gastrectomy

Start date: July 2014
Phase: N/A
Study type: Interventional

Sleeve gastrectomy (SG) has gained popularity as both a staged and a definitive procedure for morbid obesity due to its technical simplicity, low-morbidity and excellent results both for weight loss and control of metabolic syndrome. There are however reports of SG worsening pre-existing GERD or causing new-onset GERD. Because of this, patients with pre-existing GERD have been denied the benefits of SG. In addition, patients that develop post-op GERD cannot undergo traditional anti-reflux surgery since the gastric fundus that is required for fundoplication is removed during the SG. Hence, patients with post-SG GERD not adequately controlled with medication can only opt for the more invasive gastric bypass procedure as their only surgical treatment option. In a recently reported case study, an obese patient with severe GERD successfully treated with EndoStim underwent SG and maintained adequate GERD control with continued use of LES stimulation therapy. However electrical stimulation was not yet tested systematically in patients with prior gastric operation such as sleeve gastrectomy. This study will test the hypothesis that electrical stimulation is effective in control of GERD associated with SG.

NCT ID: NCT01799967 Recruiting - GERD Clinical Trials

Minimally Invasive Surgery of the Gastro-esophageal Junction

MISGEJ
Start date: November 2007
Phase:
Study type: Observational

This study will assess short and long term outcomes of individuals undergoing minimally invasive surgery of the gastro-esophageal junction (MISGEJ). Patients will respond to questionnaires on an annual basis evaluating quality of life and functionality following MISGEJ. Hospital charts will also be reviewed on an annual basis to assess patient health outcomes.

NCT ID: NCT01129713 Recruiting - Heartburn Clinical Trials

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Start date: May 2010
Phase: Phase 1/Phase 2
Study type: Interventional

To compare the complete healing of erosive esophagitis(EE) after 3 weeks of treatment with Secretol 80/80 versus Nexium 40 mg daily.

NCT ID: NCT00260585 Recruiting - Esophageal Cancer Clinical Trials

Esophageal Cancer Risk Registry

Start date: June 1999
Phase:
Study type: Observational

The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical history, blood, and tissue samples from patients who present with an esophageal disorder. Identifying genetic and behavioral risk factors involved in the development of esophageal cancer might allow for early detection and prevention. Survival and an opportunity for a cure with esophageal cancer will depend greatly on the stage of diagnosis. Tumors can develop changes in their genetic (hereditary) make-up, and these changes can sometimes be seen in normal tissues before the development of cancer. These genetic (hereditary) changes can serve as tumor markers and can be detected using methods that study changes in genetic material like DNA and RNA. The analysis of proteins can provide additional information. By identifying changes in these molecules that are different or altered in cancer, the investigators can use methods and tests for the detection of these changes.